To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Soquelitinib has been shown to affect T cell differentiation and induce the generation of Th1 helper cells while blocking the development of both Th2 and Th17 cells and production of their secreted ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Planegg/Martinsried, November 12, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor ...

Also in July 2024, Checkpoint announced a collaboration to explore the combined therapeutic potential of cosibelimab, its ...

Medically reviewed by Valerie Cacho, MD Sleep is beneficial for your immune system, and getting enough sleep is especially ...

best-in-class potential due to highly potent 4-1BB agonist antibody via simultaneous binding to two 4-1BB molecules for ...

Pro forma cash and investment balance of $683.9 million as of September 30, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones. WATER ...

The virus infects kidney cells directly, using specific receptors to damage tissues, similar to its effects on the lungs and ...

A Phase I study of invikafusp alfa presented at SITC provided the rationale to enroll patients with TMB-high, MSI-high, and virus-associated tumors in Phase II.